Hepion Pharmaceuticals Inc logo

Hepion Pharmaceuticals Inc Share Price (NASDAQ: HEPA)

$0.06

▲

-0.08

(-57.14%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 12 May 2025

Check the interactive Hepion Pharmaceuticals Inc Stock chart to analyse performance

Hepion Pharmaceuticals Inc Key Stats

Check Hepion Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.14
Open
$0.39
Market Capitalization
$8.2M
Today's Volume
$4.0M
Revenue TTM
$0.0
EBITDA
$-19.3M
Earnings Per Share (EPS)
$-2278.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-487.03%

Global Institutional Holdings in Hepion Pharmaceuticals Inc

  • Name

    Holdings %

  • Anson Funds Management LP

    0.43%

  • BlackRock Inc

    0.15%

  • Vanguard Group Inc

    0.09%

  • Geode Capital Management, LLC

    0.08%

  • Susquehanna International Group, LLP

    0.05%

  • Renaissance Technologies Corp

    0.03%

Analyst Recommendation on Hepion Pharmaceuticals Inc Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hepion Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, HDV, and HIV-1. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Organization
Hepion Pharmaceuticals Inc
Employees
0
CEO
Mr. John Patrick Brancaccio C.P.A.
Industry
Health Technology

Key Management of Hepion Pharmaceuticals Inc

NameTitle
Mr. John Patrick Brancaccio C.P.A.
Interim CEO, Interim CFO & Chairman of the Board
Sharen Pyatetskaya
Director of Investor Relations

Important FAQs about investing in HEPA Stock from India :

What is Hepion Pharmaceuticals Inc share price today?

Hepion Pharmaceuticals Inc share price today is $0.06 as on at the close of the market. Hepion Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Hepion Pharmaceuticals Inc share?

Hepion Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Hepion Pharmaceuticals Inc stock price today i.e. is closed at $0.06, lower by 99.91% versus the 52 week high.

How to invest in Hepion Pharmaceuticals Inc Stock (HEPA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Hepion Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hepion Pharmaceuticals Inc Shares that will get you 25.0000 shares as per Hepion Pharmaceuticals Inc share price of $0.06 per share as on May 12, 2025 at 12:00 AM IST.

What is the minimum amount required to buy Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Indian investors can start investing in Hepion Pharmaceuticals Inc (HEPA) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Hepion Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Hepion Pharmaceuticals Inc share’s latest price of $0.06 as on May 12, 2025 at 12:00 AM IST, you will get 166.6667 shares of Hepion Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Hepion Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Hepion Pharmaceuticals Inc stock has given 0.0% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?